A citation-based method for searching scientific literature

Moriah Bergwerk, Tal Gonen, Yaniv Lustig, Sharon Amit, Marc Lipsitch, Carmit Cohen, Michal Mandelboim, Einav Gal Levin, Carmit Rubin, Victoria Indenbaum, Ilana Tal, Malka Zavitan, Neta Zuckerman, Adina Bar-Chaim, Yitshak Kreiss, Gili Regev-Yochay. N Engl J Med 2021
Times Cited: 544







List of co-cited articles
456 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E Schlub, Adam K Wheatley, Jennifer A Juno, Kanta Subbarao, Stephen J Kent, James A Triccas, Miles P Davenport. Nat Med 2021
36

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
32

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
23

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel-Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech,[...]. Nature 2021
928
22

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera,[...]. N Engl J Med 2021
18

Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
Yinon M Bar-On, Yair Goldberg, Micha Mandel, Omri Bodenheimer, Laurence Freedman, Nir Kalkstein, Barak Mizrahi, Sharon Alroy-Preis, Nachman Ash, Ron Milo,[...]. N Engl J Med 2021
466
17

Evidence for antibody as a protective correlate for COVID-19 vaccines.
Kristen A Earle, Donna M Ambrosino, Andrew Fiore-Gartland, David Goldblatt, Peter B Gilbert, George R Siber, Peter Dull, Stanley A Plotkin. Vaccine 2021
312
14

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.
Noa Dagan, Noam Barda, Eldad Kepten, Oren Miron, Shay Perchik, Mark A Katz, Miguel A Hernán, Marc Lipsitch, Ben Reis, Ran D Balicer. N Engl J Med 2021
14

Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months.
Einav G Levin, Yaniv Lustig, Carmit Cohen, Ronen Fluss, Victoria Indenbaum, Sharon Amit, Ram Doolman, Keren Asraf, Ella Mendelson, Arnona Ziv,[...]. N Engl J Med 2021
464
12

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan,[...]. Lancet 2021
656
12

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian Angus, Vicky L Baillie, Shaun L Barnabas, Qasim E Bhorat,[...]. Lancet 2021
11

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.
Talia Kustin, Noam Harel, Uriah Finkel, Shay Perchik, Sheri Harari, Maayan Tahor, Itamar Caspi, Rachel Levy, Michael Leshchinsky, Shifra Ken Dror,[...]. Nat Med 2021
183
10

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Jennifer M Dan, Jose Mateus, Yu Kato, Kathryn M Hastie, Esther Dawen Yu, Caterina E Faliti, Alba Grifoni, Sydney I Ramirez, Sonya Haupt, April Frazier,[...]. Science 2021
10


Waning Immunity after the BNT162b2 Vaccine in Israel.
Yair Goldberg, Micha Mandel, Yinon M Bar-On, Omri Bodenheimer, Laurence Freedman, Eric J Haas, Ron Milo, Sharon Alroy-Preis, Nachman Ash, Amit Huppert. N Engl J Med 2021
333
10

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Florian Krammer, Komal Srivastava, Hala Alshammary, Angela A Amoako, Mahmoud H Awawda, Katherine F Beach, Maria C Bermúdez-González, Dominika A Bielak, Juan M Carreño, Rachel L Chernet,[...]. N Engl J Med 2021
394
9

Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings - Barnstable County, Massachusetts, July 2021.
Catherine M Brown, Johanna Vostok, Hillary Johnson, Meagan Burns, Radhika Gharpure, Samira Sami, Rebecca T Sabo, Noemi Hall, Anne Foreman, Petra L Schubert,[...]. MMWR Morb Mortal Wkly Rep 2021
248
9

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
Daming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, Chang Liu, Alexander J Mentzer, Helen M Ginn, Yuguang Zhao, Helen M E Duyvesteyn, Aekkachai Tuekprakhon, Rungtiwa Nutalai,[...]. Cell 2021
546
9

BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel.
Tal Brosh-Nissimov, Efrat Orenbuch-Harroch, Michal Chowers, Meital Elbaz, Lior Nesher, Michal Stein, Yasmin Maor, Regev Cohen, Khetam Hussein, Miriam Weinberger,[...]. Clin Microbiol Infect 2021
128
9

Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals following mRNA vaccination.
Rishi R Goel, Sokratis A Apostolidis, Mark M Painter, Divij Mathew, Ajinkya Pattekar, Oliva Kuthuru, Sigrid Gouma, Philip Hicks, Wenzhao Meng, Aaron M Rosenfeld,[...]. Sci Immunol 2021
262
9

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection.
Shuo Feng, Daniel J Phillips, Thomas White, Homesh Sayal, Parvinder K Aley, Sagida Bibi, Christina Dold, Michelle Fuskova, Sarah C Gilbert, Ian Hirsch,[...]. Nat Med 2021
343
9

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection.
Zijun Wang, Frauke Muecksch, Dennis Schaefer-Babajew, Shlomo Finkin, Charlotte Viant, Christian Gaebler, Hans- Heinrich Hoffmann, Christopher O Barnes, Melissa Cipolla, Victor Ramos,[...]. Nature 2021
290
9

SARS-CoV-2 Infection after Vaccination in Health Care Workers in California.
Jocelyn Keehner, Lucy E Horton, Michael A Pfeffer, Christopher A Longhurst, Robert T Schooley, Judith S Currier, Shira R Abeles, Francesca J Torriani. N Engl J Med 2021
140
8

Vaccine Breakthrough Infections with SARS-CoV-2 Variants.
Ezgi Hacisuleyman, Caryn Hale, Yuhki Saito, Nathalie E Blachere, Marissa Bergh, Erin G Conlon, Dennis J Schaefer-Babajew, Justin DaSilva, Frauke Muecksch, Christian Gaebler,[...]. N Engl J Med 2021
347
8

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
8

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients.
Nassim Kamar, Florence Abravanel, Olivier Marion, Chloé Couat, Jacques Izopet, Arnaud Del Bello. N Engl J Med 2021
420
8

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Chelsea Sawyer, Rodney Daniels, Philip Hobson, Emine Hatipoglu, Yenting Ngai,[...]. Lancet 2021
275
8

SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
Jackson S Turner, Jane A O'Halloran, Elizaveta Kalaidina, Wooseob Kim, Aaron J Schmitz, Julian Q Zhou, Tingting Lei, Mahima Thapa, Rita E Chen, James Brett Case,[...]. Nature 2021
233
8

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, Timothy B Frankland, Oluwaseye A Ogun, Joann M Zamparo, Sharon Gray,[...]. Lancet 2021
397
8

A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.
Chee Wah Tan, Wan Ni Chia, Xijian Qin, Pei Liu, Mark I-C Chen, Charles Tiu, Zhiliang Hu, Vivian Chih-Wei Chen, Barnaby E Young, Wan Rong Sia,[...]. Nat Biotechnol 2020
556
8

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia.
Yair Herishanu, Irit Avivi, Anat Aharon, Gabi Shefer, Shai Levi, Yotam Bronstein, Miguel Morales, Tomer Ziv, Yamit Shorer Arbel, Lydia Scarfò,[...]. Blood 2021
319
7

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Zijun Wang, Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, Christopher O Barnes, Shlomo Finkin, Dennis Schaefer-Babajew, Melissa Cipolla, Christian Gaebler, Jenna A Lieberman,[...]. Nature 2021
777
7

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.
Edward E Walsh, Robert W Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey,[...]. N Engl J Med 2020
7

Evolution of antibody immunity to SARS-CoV-2.
Christian Gaebler, Zijun Wang, Julio C C Lorenzi, Frauke Muecksch, Shlomo Finkin, Minami Tokuyama, Alice Cho, Mila Jankovic, Dennis Schaefer-Babajew, Thiago Y Oliveira,[...]. Nature 2021
727
7

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study.
Paul Naaber, Liina Tserel, Kadri Kangro, Epp Sepp, Virge Jürjenson, Ainika Adamson, Liis Haljasmägi, Anna Pauliina Rumm, Regina Maruste, Jaanika Kärner,[...]. Lancet Reg Health Eur 2021
200
7

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
Hiam Chemaitelly, Patrick Tang, Mohammad R Hasan, Sawsan AlMukdad, Hadi M Yassine, Fatiha M Benslimane, Hebah A Al Khatib, Peter Coyle, Houssein H Ayoub, Zaina Al Kanaani,[...]. N Engl J Med 2021
278
7

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald Sadoff, Glenda Gray, An Vandebosch, Vicky Cárdenas, Georgi Shukarev, Beatriz Grinsztejn, Paul A Goepfert, Carla Truyers, Hein Fennema, Bart Spiessens,[...]. N Engl J Med 2021
934
7

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.
Wan Ni Chia, Feng Zhu, Sean Wei Xiang Ong, Barnaby Edward Young, Siew-Wai Fong, Nina Le Bert, Chee Wah Tan, Charles Tiu, Jinyan Zhang, Seow Yen Tan,[...]. Lancet Microbe 2021
158
7

Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis.
Ayelet Grupper, Nechama Sharon, Talya Finn, Regev Cohen, Meital Israel, Amir Agbaria, Yoav Rechavi, Idit F Schwartz, Doron Schwartz, Yonatan Lellouch,[...]. Clin J Am Soc Nephrol 2021
165
6

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.
Nicole Doria-Rose, Mehul S Suthar, Mat Makowski, Sarah O'Connell, Adrian B McDermott, Britta Flach, Julie E Ledgerwood, John R Mascola, Barney S Graham, Bob C Lin,[...]. N Engl J Med 2021
331
6

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
Charlotte Manisty, Ashley D Otter, Thomas A Treibel, Áine McKnight, Daniel M Altmann, Timothy Brooks, Mahdad Noursadeghi, Rosemary J Boyton, Amanda Semper, James C Moon. Lancet 2021
223
6

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines.
Mark G Thompson, Jefferey L Burgess, Allison L Naleway, Harmony Tyner, Sarang K Yoon, Jennifer Meece, Lauren E W Olsho, Alberto J Caban-Martinez, Ashley L Fowlkes, Karen Lutrick,[...]. N Engl J Med 2021
189
6

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
Laith J Abu-Raddad, Hiam Chemaitelly, Adeel A Butt. N Engl J Med 2021
491
6

Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
Madhumita Shrotri, Annalan M D Navaratnam, Vincent Nguyen, Thomas Byrne, Cyril Geismar, Ellen Fragaszy, Sarah Beale, Wing Lam Erica Fong, Parth Patel, Jana Kovar,[...]. Lancet 2021
152
6

Correlates of protection against SARS-CoV-2 in rhesus macaques.
Katherine McMahan, Jingyou Yu, Noe B Mercado, Carolin Loos, Lisa H Tostanoski, Abishek Chandrashekar, Jinyan Liu, Lauren Peter, Caroline Atyeo, Alex Zhu,[...]. Nature 2021
521
6

An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.
Lisa A Jackson, Evan J Anderson, Nadine G Rouphael, Paul C Roberts, Mamodikoe Makhene, Rhea N Coler, Michele P McCullough, James D Chappell, Mark R Denison, Laura J Stevens,[...]. N Engl J Med 2020
6

Considerations in boosting COVID-19 vaccine immune responses.
Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Jonathan A C Sterne, Alejandro Cravioto, Helen Rees, Julian P T Higgins, Isabelle Boutron,[...]. Lancet 2021
119
6

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Leticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, Duncan R McKenzie, Irene Del Molino Del Barrio, Thanussuyah Alaguthurai, Clara Domingo-Vila, Thomas S Hayday, Carl Graham, Jeffrey Seow,[...]. Lancet Oncol 2021
280
6

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months.
Stephen J Thomas, Edson D Moreira, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Fernando P Polack, Cristiano Zerbini,[...]. N Engl J Med 2021
429
6

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies.
Rita E Chen, Xianwen Zhang, James Brett Case, Emma S Winkler, Yang Liu, Laura A VanBlargan, Jianying Liu, John M Errico, Xuping Xie, Naveenchandra Suryadevara,[...]. Nat Med 2021
517
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.